Spanish biotech SpliceBio has raised $135 million in financing that will help it move a gene-editing therapy for an inherited retinal disease (IRD) through clinical testing. SpliceBio's lead in-house ...

Find out how much you know about the week’s local news, and see how you do against other Times Union readers. We’ll upload a new batch of questions Friday morning. Sign up for our news quiz email, and ...

Would you rather give up all social media forever or give up all forms of entertainment (TV, movies, music) forever? Would you rather only be able to whisper for the rest of your life or only shout?

All our brain-teasers in one place. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.